Ultralife (NASDAQ:ULBI) Receives "Hold (C-)" Rating from Weiss Ratings

Key Points

• Ultralife's stock has been given a "hold (C-)" rating by Weiss Ratings, indicating a cautious stance on the company's performance.
• The company reported an EPS of $0.07 for the last quarter, missing analysts' expectations and resulting in a net margin of only 1.79%.
• Insider trading activity saw Director Bradford T. Whitmore acquire 29,766 shares at an average price of $6.63, increasing his ownership in the company.

Ultralife (NASDAQ:ULBI - Get Free Report)'s stock had its "hold (c-)" rating reiterated by equities researchers at Weiss Ratings in a research report issued to clients and investors on Friday,Weiss Ratings reports.

Separately, Wall Street Zen cut Ultralife from a "strong-buy" rating to a "hold" rating in a research report on Saturday, September 13th. One research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. According to MarketBeat.com, Ultralife currently has a consensus rating of "Moderate Buy" and a consensus price target of $14.00.

Ultralife Stock Performance

Shares of NASDAQ ULBI traded up $0.21 during trading hours on Friday, reaching $6.95. The stock had a trading volume of 23,458 shares, compared to its average volume of 55,878. The business's fifty day moving average is $6.86 and its two-hundred day moving average is $6.82. The company has a debt-to-equity ratio of 0.34, a current ratio of 3.31 and a quick ratio of 1.62. The company has a market cap of $115.65 million, a price-to-earnings ratio of 36.58 and a beta of 1.06. Ultralife has a twelve month low of $4.07 and a twelve month high of $9.61.

Ultralife (NASDAQ:ULBI - Get Free Report) last issued its earnings results on Thursday, August 7th. The technology company reported $0.07 EPS for the quarter, missing analysts' consensus estimates of $0.14 by ($0.07). Ultralife had a net margin of 1.79% and a return on equity of 2.68%. The firm had revenue of $48.56 million during the quarter, compared to analyst estimates of $51.00 million.

Insider Activity at Ultralife

In other Ultralife news, Director Bradford T. Whitmore bought 29,766 shares of the firm's stock in a transaction dated Thursday, August 21st. The shares were bought at an average price of $6.63 per share, for a total transaction of $197,348.58. Following the completion of the acquisition, the director owned 1,128,731 shares of the company's stock, valued at approximately $7,483,486.53. This trade represents a 2.71% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders acquired a total of 58,664 shares of company stock worth $387,049 in the last quarter. 40.00% of the stock is currently owned by corporate insiders.

Institutional Trading of Ultralife

Large investors have recently made changes to their positions in the business. Lazard Asset Management LLC grew its holdings in shares of Ultralife by 1,650.0% during the second quarter. Lazard Asset Management LLC now owns 5,565 shares of the technology company's stock worth $49,000 after purchasing an additional 5,247 shares during the last quarter. IFP Advisors Inc grew its holdings in shares of Ultralife by 24.6% during the first quarter. IFP Advisors Inc now owns 14,200 shares of the technology company's stock worth $76,000 after purchasing an additional 2,800 shares during the last quarter. Jones Financial Companies Lllp grew its holdings in shares of Ultralife by 1,428.7% during the first quarter. Jones Financial Companies Lllp now owns 15,287 shares of the technology company's stock worth $82,000 after purchasing an additional 14,287 shares during the last quarter. Bank of America Corp DE grew its holdings in shares of Ultralife by 30.7% during the fourth quarter. Bank of America Corp DE now owns 12,067 shares of the technology company's stock worth $90,000 after purchasing an additional 2,836 shares during the last quarter. Finally, Nuveen LLC bought a new stake in shares of Ultralife during the first quarter worth $116,000. Institutional investors own 30.68% of the company's stock.

Ultralife Company Profile

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.